RBL2(Retinoblastoma-like 2),也称为p130,是视网膜母细胞瘤蛋白(RB)基因家族的成员之一,该家族还包括RB1和RBL1(p107)。这些基因的共同特点是编码肿瘤抑制蛋白,通过调控细胞周期进程(特别是G1期到S期的过渡)来抑制细胞过度增殖。RBL2的主要功能是与转录因子E2F家族成员结合,抑制其活性,从而阻止细胞周期相关基因的表达,确保细胞在DNA损伤或其他异常情况下不会不受控地分裂。RBL2在多种组织中广泛表达,尤其在终末分化细胞中发挥维持细胞静止状态的作用。RBL2的突变或表达异常可能导致细胞周期失控,与多种癌症(如肺癌、乳腺癌和结直肠癌)的发生密切相关。当RBL2表达降低时,细胞更容易进入增殖状态,增加肿瘤风险;而过表达则可能导致细胞周期停滞,影响组织再生或修复。此外,RBL2还参与细胞衰老、分化和凋亡等过程,并与病毒感染(如HPV)相关的癌变机制有关。RBL2的功能也受CDK(周期蛋白依赖性激酶)介导的磷酸化调控,其失活突变或启动子甲基化导致的沉默常见于某些恶性肿瘤。在基因家族中,RB1、RBL1和RBL2均通过类似的E2F调控通路抑制细胞增殖,但它们在组织分布和细胞周期阶段中的作用略有差异。例如,RBL2在G0期和早期G1期作用更突出,而RB1在G1晚期调控中更关键。研究RBL2有助于理解肿瘤发生机制并开发靶向细胞周期的抗癌疗法。
Subcellular localization of RBL2 (and its protein):
Gene Ontology (GO) terms for RBL2:
| Interacting Gene | Interaction | Source/Score |
| Name |
|---|
| 4068 FoxO signaling pathway [PATH:hsa04068] |
| 4151 PI3K-Akt signaling pathway [PATH:hsa04151] |
| 4110 Cell cycle [PATH:hsa04110] |
| 5203 Viral carcinogenesis [PATH:hsa05203] |
| Name |
|---|
| Cell Cycle |
| Cell Cycle, Mitotic |
| Cyclin D associated events in G1 |
| G0 and Early G1 |
| G1 Phase |
| Mitotic G1-G1/S phases |
| Disease | Score | NofPmids | NofSnps | Source |
| Chronic Lymphocytic Leukemia | 0.122638474 | 2 | 0 | BeFree_CTD_human_GAD |
| ovarian neoplasm | 0.12 | 1 | 0 | CTD_human |
| Retinoblastoma | 0.006786047 | 25 | 0 | BeFree |
| Liver carcinoma | 0.005720142 | 3 | 0 | BeFree_LHGDN |
| Mammary Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
| Lung Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
| Prostatic Neoplasms | 0.0054487 | 2 | 0 | LHGDN |
| Squamous cell carcinoma | 0.003810118 | 4 | 0 | BeFree_LHGDN |
| Burkitt Lymphoma | 0.002995792 | 1 | 0 | BeFree_LHGDN |
| Lymphoma, AIDS-Related | 0.002995792 | 2 | 0 | BeFree_LHGDN |
No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong
Qilu Normal University · Genelibs Bioinformatics Lab
750 Shunhua Rd, Jinan
2F, Bldg F, University Science Park
Tel: 0531-88819269
Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.
Business Email
E-mail: [email protected]